This study tests an oral drug called APG-157 in 24 people with newly diagnosed head and neck cancer. The goal is to see if taking the drug before standard treatments like surgery can shrink tumors and improve outcomes. Researchers will measure tumor size changes using scans and c…
Phase: PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated May 17, 2026 07:27 UTC